Catalyst Wire Dossier Catalyst Wire Dossier

CEP-26401

CEP-26401 · Teva Branded Pharmaceutical Products R&D, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CEP-26401, covering 2014-04-03 to 2014-04-03. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetics and Pharmacodynamics (PK/PD) of CEP-26401 in Healthy Subjects [Phase 1]

See pricing